Home › Trial NCT03123952
Expanded Access to ABT-414
- Trial IDNCT03123952
- StatusUnknown
- PhaseN/A
- Study typeExpanded_Access
- SponsorAbbVie
- Enrollment—
- Start date—
- ConditionsGlioblastoma or Solid Tumors, Epidermal Growth Factor Receptor (EGFR) Diagnosis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.